Navigation Links
Majority of Herb Users Don't Follow Evidence-based Indications, Researchers Find

Sales of herbal dietary supplements have skyrocketed by 100 percent in the United States during the last 10 years, but most people dont consider evidence-based indications before using them, according to a University of Iowa study published in this months Mayo Clinic Proceedings.

Two-thirds of people who use herbs dont do so in accordance with scientific guidelines, according to the article. Meanwhile, sales of herbal supplements reached $18.8 billion in 2003, up 100 percent from $8.8 billion in 1994. Those sales are subject to minimal federal regulations.

Physicians are concerned, says Aditya Bardia, M.D., lead author of the study and a resident in the Department of Internal Medicine at Mayo Clinic, because herbal supplements can have adverse side effects and interact negatively with therapeutic drugs. Physicians should ask patients about herb use during every clinical visit and hospital admission to better inform patients about potential benefits and harm, agree the studys authors.

Physicians, pharmacists and other health professionals should proactively educate consumers and advocate for public health policies that would disseminate evidence-based information regarding the appropriate use of herbs, Dr. Bardia says.

To generate their findings, physicians culled information from a 2002 National Health Interview Survey taken among U.S. adults. The final study population, 609 adults, took a single herb and said they were taking it to treat a specific health condition.

The study found that only one-third of this population took the herbal preparation for a known scientific indication. Dr. Bardia cautions that further study is warranted as the efficacy of herb use evolves and says much more needs to be learned about the clinical indications for individual herbs.


'"/>




Page: 1

Related medicine news :

1. Majority Of Women Satisfied With Decision To Have Preventive Mastectomy
2. Majority Of Americans Deny That They Are Overweight
3. Majority of Middle Aged People Suffer from - High BP, High Sugar, Pot Belly
4. Majority of Keralites Vote in Favor of HIV Certificate Before Marriage
5. Majority Of People In US Seek Essential Changes In Health Care System
6. Majority Chinese Men Lack Testosterone: Report
7. Majority Of The Flu Vaccine Supply Received
8. Majority Of Doctors Tend To Ignore Milk Allergy Cases In Babies
9. Majority of Padma Awards Go to Doctors from Delhi
10. Harassment in School Affects Majority of Elementary Students
11. Majority of Europeans in Favor of Smoking Ban in Public Places
Post Your Comments:
Other Medicine News:Health News:Autism Speaks Applauds Supreme Court Decision Upholding Families' Right to Challenge IEPs Without First Trying Out School District Proposed Placement 2Health News:Autism Speaks Applauds Supreme Court Decision Upholding Families' Right to Challenge IEPs Without First Trying Out School District Proposed Placement 3Health News:Mouse mammary tumor virus can replicate in human cells 2Health News:Health IT Now! Coalition Applauds Representatives Eshoo and Rogers for Introducing Health IT Legislation 2Health News:Salmonella Outbreak Traced to Banquet and Store Brand Frozen Pot Pies 2Health News:PRI Criticizes Guttmacher Report 2Health News:Study reveals how stem cells decide to become either skeletal or smooth muscle 2Health News:Study reveals how stem cells decide to become either skeletal or smooth muscle 3Health News:Study reveals how stem cells decide to become either skeletal or smooth muscle 4Health News:Study reveals how stem cells decide to become either skeletal or smooth muscle 5
Breaking Medicine Technology:Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 2Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 3Seven New Biopharmaceutical Research Companies Join PhRMA's Mission to Advance Medical Innovation 4Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3Ser Padres Joins Forces with la Doctora Alizas VidaySalud com to Offer the Hispanic Community Unprecedented Online Health Related Content in Spanish 49632 1Ser Padres Joins Forces with la Doctora Alizas VidaySalud com to Offer the Hispanic Community Unprecedented Online Health Related Content in Spanish 49632 2Ser Padres Joins Forces with la Doctora Alizas VidaySalud com to Offer the Hispanic Community Unprecedented Online Health Related Content in Spanish 49632 3Transcend Medical Raises 2435 Million Series B Round Towards Development of Novel Glaucoma Treatment 49630 1Transcend Medical Raises 2435 Million Series B Round Towards Development of Novel Glaucoma Treatment 49630 2DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture 28EDC 29 Clinical Trial Survey 4626 1DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture 28EDC 29 Clinical Trial Survey 4626 2
Other Medicine Technology:New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 2New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 3New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 4New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 5New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 6New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 7New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI) 8Siemens Corporate Research Develops RAPID2 System for Fast Discovery of Discriminative Pathogen Signatures 2